Artificial intelligence is increasingly revolutionizing oncologic diagnostics. Notably, Uppsala University developed AI capable of detecting prostate cancer cases missed by pathologists, enhancing early diagnosis. Furthermore, Tempus AI's acquisition of digital pathology firm Paige enriches datasets for building expansive oncology foundation models. These advances promise improved patient stratification, earlier interventions, and precision oncology.